Enyo Pharma
ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.
7-day free trial · no credit card
Verified contacts
20
available on Kipplo
LinkedIn employees
37
11 to 50 range
Open roles
—
no listings
Distinct roles
19
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 20 verified contacts at Enyo Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
20 contacts with verified email or phone · masked until revealed.
- PM
Pierre Mallinjoud
Ingénieur Bioinformatique · Science
EmailPhone - DB
Delphine Buforn
Human Resources and G & a Manager · Other
EmailPhone - PS
Pietro Scalfaro
Chief Medical Officer · Healthcare & Human Services
EmailPhone
Showing 3 of 20 verified contacts
Top roles at Enyo Pharma
19 distinct titles indexed · top 10 shown.
- 2é é
- 1accountany
- 1assistante essais cliniques
- 1bis
- 1chief medical officer
- 1construction supervisor
- 1head of clinical operations
- 1head of the ceo project office
- 1human resources and g & a manager
- 1human resources associate
- +9more titles
Sign up to unlock all 20 contacts at Enyo Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 20 verified contacts at Enyo Pharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.